Masaharu Shinkai

5PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsInnate immunityGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 14, 2025
Explainable Machine Learning Framework for Dynamic Monitoring of Disease Prognostic Risk: Retrospective Cohort Study.

Tetsuo Ishikawa, Masahiro Shinoda, Megumi Oya

|Aug 21, 2024
Repeated Omicron exposures redirect SARS-CoV-2-specific memory B cell evolution toward the latest variants.

Ryutaro Kotaki, Saya Moriyama, Shintaro Oishi

|Jun 14, 2023
CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes.

Taishi Onodera, Nicolas Sax, Takashi Sato

|Oct 14, 2021
Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients.

Xiuyuan Lu, Yuki Hosono, Masamichi Nagae

|Oct 08, 2021
Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses.

Ryo Shinnakasu, Shuhei Sakakibara, Hiromi Yamamoto

Pageof 1